---
title: "ANNX.US (ANNX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ANNX.US/news.md"
symbol: "ANNX.US"
name: "ANNX.US"
parent: "https://longbridge.com/en/quote/ANNX.US.md"
datetime: "2026-06-13T20:59:45.795Z"
locales:
  - [en](https://longbridge.com/en/quote/ANNX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ANNX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ANNX.US/news.md)
---

# ANNX.US (ANNX.US) — Related News

### [Annexon Stockholders Approve Directors, Compensation and Share Increase](https://longbridge.com/en/news/289645814.md)
*2026-06-12T22:27:41.000Z*
> Annexon Biosciences shareholders approved director elections, executive compensation, KPMG appointment, and increased au

### [Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead](https://longbridge.com/en/news/289195172.md)
*2026-06-09T13:06:41.000Z*
> Annexon executives outlined upcoming catalysts at the Goldman Sachs Healthcare Conference. Key focus includes Q4 Phase I

### [Annexon Maps 3 Big Pipeline Catalysts Ahead of Q4 Vision-Drug Readout](https://longbridge.com/en/news/288679260.md)
*2026-06-04T07:07:07.000Z*
> Annexon (NASDAQ: ANNX) executives outlined three major pipeline catalysts at the Jefferies Conference. Key updates inclu

### [Monday 6/1 Insider Buying Report: ANNX, CDNL](https://longbridge.com/en/news/288303523.md)
*2026-06-01T16:10:26.000Z*
> On June 1, insider buying reports highlighted two transactions. Muneer A. Satter purchased 613,497 shares of Annexon (AN

### [Annexon Highlights Q4 Geographic Atrophy Data, GBS Filing Plans at BofA Conference](https://longbridge.com/en/news/286528687.md)
*2026-05-14T08:05:47.000Z*
> Annexon (NASDAQ: ANNX) CEO Doug Love presented the company's late-stage pipeline at the Bank of America Healthcare Confe

### [Annexon (NASDAQ:ANNX) Upgraded by The Goldman Sachs Group to "Hold" Rating](https://longbridge.com/en/news/286233633.md)
*2026-05-13T09:37:34.000Z*
> The Goldman Sachs Group upgraded Annexon (NASDAQ:ANNX) to a "hold" rating. Other analysts have varied opinions, with Cha

### [HC Wainwright Has Optimistic View of Annexon FY2030 Earnings](https://longbridge.com/en/news/285887802.md)
*2026-05-11T05:55:38.000Z*
> HC Wainwright has raised its FY2030 EPS estimate for Annexon, Inc. to $0.56 from $0.43, while the consensus estimate for

### [Annexon (NASDAQ:ANNX) Announces Quarterly Earnings Results, Beats Expectations By $0.07 EPS](https://longbridge.com/en/news/285663588.md)
*2026-05-08T04:35:28.000Z*
> Annexon (NASDAQ:ANNX) reported quarterly earnings of ($0.23) EPS, surpassing expectations by $0.07. The stock traded dow

### [Annexon CEO Touts “Win Year” 2026 at Needham, Eyes GA Phase III Data and GBS FDA Filing](https://longbridge.com/en/news/282899248.md)
*2026-04-15T21:02:07.000Z*
> Annexon CEO Doug Love announced at the Needham Healthcare Conference that 2026 will be a "win year" for the company, hig